Researchers at UCLA believe using the patient’s own cells to create stem cells for therapeutic purposes is the future of medicine. A recently published study by scientists at UCLA demonstrates how specialized proteins change the cellular characteristics of skin cells to create induced pluripotent stem cells. These stem cells have the ability to turn into any cell type within the body. Also at UCLA, a clinical trial which uses the baby’s own blood-forming stem cells to treat the immune deficiency condition ADA-SCID, better known as “bubble baby disease,” was recently awarded a $20M grant from the California Institute for Regenerative Medicine.Read More
Science Market Update
Dr. Madelaine Bartlett, a biologist at the University of Massachusetts in Amherst, recently received a four-year $4 million grant from the National Science Foundation. The new research funding will allow Barlett and colleagues from UMass and other institutions to study the genes that regulate plant stem cell biology and their effect on fruit size and yield.Read More
Tags: Stem cell research, University of Massachusetts Amherst, University of Massachusetts, agriculture, new research funding, Massachusetts, agricultural, MA, Northeast Region, UMASS, new research grant, NSF funding, NSF grant, NSF award, Plant Biology, agricultural business, agribusiness
Researchers at the University of Colorado, Boulder have recently discovered information about stem cell division that may change the way we approach regenerative medicine and cancer research. These findings were published as the cover story in Science for its February 5th issue.Read More
(Original article from 2012 by Jaimee Saliba. Updated information added by Katey Rein.)
The University of Pittsburgh has strong ties with the Pittsburgh Veteran's Administration Medical Center located next door, and in the past few years those relations have been strengthened with the establishment of the UP School of Medicine Center for Military Medicine Research as well as a new research facility at the VA's University Drive campus.
An estimated 30,000 people in the United States are afflicted with Huntington’s disease. Receiving a diagnosis of this genetic neurodegenerative disorder is unimaginably devastating. Sufferers slowly lose control of their movement and develop psychiatric problems over the course of 10-25 years, and often the disease is undetected until adulthood. Just this year, UC Davis researchers in Sacramento, California have discovered that human mesenchymal stem cells (MSCs) - cells with the ability to differentiate into bone cells, muscle cells, and other cell types - could be the key to developing an effective new therapy to treat Huntington’s. The promising findings are published in the journal Molecular Therapy.Read More
Millions of people suffer from allergies nationwide, (up to 30% of Americans, according to the Center for Disease Control), but for most, a healthy immune system and a course of antihistamines is all that is needed for a little relief.
For others, however, diseases that complicate and degrade the immune system make every microbe and bacteria a potentially fatal nightmare. In recent years, people suffering from immune deficiencies have found some home in stem-cell transplants and other therapies, but their hope is tempered by inherent toxicities and associated side effects.Read More
Tags: Fred Hutchinson Cancer Research Center, Washington, immunotherapy, Stem cell research, WA, NIH funded Research Projects, Immune System, grants, 2015, BioResearch Product Faire Event, Research Funding, Stem Cell, Seattle, Northwest Region, Hutch, Fred Hutch
Hypothalamic neurons orchestrate many essential physiological and behavioral processes via secreted neuropeptides, and are relevant to human diseases such as obesity, narcolepsy and infertility. A recent collaboration of scientists from New York, Toronto, and Tokyo, and Harvard Stem Cell Institute (HSCI) researchers have devised two methods for using stem cells to generate the type of neurons that help regulate behavioral and basic physiological functions in the human body, such as obesity and hypertension, as well as sleep, mood, and some social disorders.Read More
Two prominent researchers at UC Davis are under a microscope for their work in stem-cell biotechnology. The pair from University of California, Davis was awarded close to $4 million in funding to improve biotechnology intended for physicians studying stem cell treatments.
The two grant awards, of over $1.8 million each, were awarded to Laura Marcu and Kent Leach by the California Institute for Regenerative Medicine (CIRM) to continue developing technology that is used in stem cell treatments for vascular disease, bone and cartilage repair.Read More
Young scientists often contribute in spectacular ways to bioresearch. Without adequate funding, however, many important and dedicated junior scientists are limited in how they are able to contribute to scientific understanding.
Paying for lab equipment, salaries, and adequate research resources can all be limiting factors for some scientists, but perhaps not for junior post doctoral fellows working on stem cell research at the University of Southern California.
Thanks to a recent gift from the Hearst Foundations to USC in the amount of $300,000, exceptional junior postdoctoral fellows can continue to pursue stem cell research and work on important projects at USC.Read More
A research team at the UC San Diego’s Moores Cancer Center recently received a major new grant from the California Institute for Regenerative Medicine (CIRM) for a groundbreaking cancer study. The research will be led by Thomas J. Kipps, MD, PhD, deputy director of research operations at the Moores Cancer Center and a professor of medicine at UC San Diego (Image courtesy of UCSD).